Almeida-Brasil, C. C., Hanly, J. G., Urowitz, M., Clarke, A. E., Ruiz-Irastorza, G., Gordon, C., Ramsey-Goldman, R., Petri, M., Ginzler, E. M., Wallace, D. J., Bae, S.-C., Romero-Diaz, J., Dooley, M. A., Peschken, C., Isenberg, D., Rahman, A., Manzi, S., Jacobsen, S., Lim, S., … Bernatsky, S. (2022). Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the Rheumatic Diseases, 81(3), 370–378. https://doi.org/10.1136/annrheumdis-2021-221295
Columbia Affiliation:
Subjects:
Systemic Lupus Erythematosus and Antiphospholipid Syndrome
(OpenAlex Topic)
Ocular Toxicity and Retinal Disorders from Medications
(OpenAlex Topic)
Guillain-Barré Syndrome and Related Neuropathies
(OpenAlex Topic)
Antirheumatic Agents
(MeSH)
Drug Tapering
(MeSH)
Hydroxychloroquine
(MeSH)
Symptom Flare Up
(MeSH)
Publication Type:
Article
Unique ID:
10.1136/annrheumdis-2021-221295
PMID:
Journal:
Publication Date:
Data Source:
Scopus